Gene expression profiling identifies molecular subgroups among nodal peripheral T-cell lymphomas.

Area of Science:

• Hematology
• Oncology
• Molecular Biology

Background:

• The classification of peripheral T-cell lymphomas (PTCL) remains complex and debated.
• Existing classifications struggle to adequately define the heterogeneous group known as PTCL, unspecified (PTCL-U).

Purpose of the Study:

• To establish a molecular classification for PTCL, focusing on the heterogeneity within PTCL-U.
• To identify distinct molecular subgroups within PTCL-U that could inform future therapeutic strategies.

Main Methods:

• Analysis of gene expression profiles from 59 primary nodal T-cell lymphomas using cDNA microarrays.
• Application of a multiclass predictor to differentiate PTCL subtypes and identify molecular signatures within PTCL-U.
• Gene Ontology analysis to determine functional differences between molecular subgroups.

Main Results:

• Molecular profiles successfully discriminated angioimmunoblastic lymphoma, anaplastic large-cell lymphoma, and T-lymphoblastic lymphoma (T-LBL).
• PTCL-U was successfully divided into three distinct molecular subgroups: U1, U2, and U3.
• U1 subgroup showed association with poor outcome genes (e.g., CCND2); U2 with T-cell activation/apoptosis genes (e.g., NFKB1, BCL-2); U3 with IFN/JAK/STAT pathway genes, including histiocyte-rich PTCL.

Conclusions:

• Distinct molecular subtypes of PTCL-U exist, characterized by unique gene expression profiles and functional pathways.
• These findings provide a foundation for refining PTCL classification and developing novel therapeutic targets for PTCL-U.
• Molecular subtyping holds promise for personalized treatment approaches in peripheral T-cell lymphomas.